Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-016-2155-y.pdf
Reference21 articles.
1. Bjorkholm M et al (2011) Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 29:2514–2520. doi: 10.1200/jco.2011.34.7146
2. Blakely T, Barendregt JJ, Foster RH, Hill S, Atkinson J, Sarfati D, Edwards R (2013) The association of active smoking with multiple cancers: national census-cancer registry cohorts with quantitative bias analysis. Cancer Causes Control 24:1243–1255. doi: 10.1007/s10552-013-0204-2
3. Brenner H, Gondos A, Pulte D (2008) Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level. Haematologica 93:1544–1549. doi: 10.3324/haematol.13045
4. Cogle CR et al (2014) High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment. Leuk Res 38:71–75. doi: 10.1016/j.leukres.2013.10.023
5. Gratwohl A, Baldomero H, Passweg J (2015) The role of hematopoietic stem cell transplantation in chronic myeloid leukemia. Ann Hematol 94(Suppl 2):S177–S186. doi: 10.1007/s00277-015-2313-3
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic;Oncohematology;2022-07-20
2. Incidence, Prevalence, and Real-World Treatment Patterns in Chronic Myeloid Leukemia: Results from a Population-Representative German Claims Data Analysis;Oncology Research and Treatment;2022
3. Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients;Russian journal of hematology and transfusiology;2021-10-25
4. Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study;Cancer Medicine;2021-02-16
5. Epidemiology of Chronic Myeloid Leukaemia;Hematologic Malignancies;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3